Memòria 2010 - IISPV

Àmbit estratègic 3. Oncologia i hematologiaBERGUA J, GONZÁLEZ J, DÍAZ-MEDIAVILLA J, RO-JAS R, MANSO F, OSSENKOPPELE G, GONZÁLEZJD, LOWENBERG B, PETHEMA AND HOVONGROUPS. Risk-adapted treatment of acutepromyelocytic leukemia based on all-transretinoic acid and anthracycline with additionof cytarabine in consolidation therapyfor high-risk patients: further improvementsin treatment autcome. Blood. 2010;24:5137-46. FI: 10,555. 1r quartil.ESINET B, SALAVERRIA I, BEÀ S, RUIZ-XIVILLÉ N, BA-LAGUÉ O, SALIDO M, COSTA D, CARRERAS J, RO-DRÍGUEZ-VICENTE AE, LUÍS GARCÍA J, HERNÁN-DEZ-RIVAS JM, CALASANZ MJ, SIEBERT R, FER-RER A, SALAR A, CARRIÓ A, POLO N, GARCÍA-MARCO JA, DOMINGO A, GONZÁLEZ-BARCA E,CID J, AGUINACO R, SÁNCHEZ R, GARCÍ-PARDO G,LLORENTE A. Neutrophil CD64 expressionas marker of bacterial iinfection: a systematicreview and meta-analysis. J Infect.2010; 60:313-9. FI: 3,060. 1r quartil.CID J, NASCIMENTO JD, VICENT A, AGUINACO R,ESCODA L, UGARRIZA A, LLORENTE A. Evaluationof low platelet counts by optical, impedanceand CD61-immunoplatelet methods:estimation of possible inappropriateplatelet transfusion. Transfusion. 2010;50:795-800. FI: 2,982. 2n quartil.ROMAGOSA V, MARUGÁN I, LÓPEZ-GUILLERMOA, MILLÀ F, LUÍS MATE J, LLUÑO E, SANZO C,COLLADO R, OLIVER I, MONZÓ S, PALACIN A,GONZÁLEZ T, SANT F, SALINAS R, ARDANAZ MT,FONT L, ESCODA L, FLORENSA L, SERRANO S,CAMPO E, SOLÉ F. Incidence and prognosticimpact of secondary cytogenetic aberrationsin a series of 145 patients with mantiecell lymphoma. Genes Chromosomes cancer.2010; 49:439-51. FI: 3,858. 2n quartil.101